- Home
- EDRY vs SRTS Comparison
EDRY vs SRTS Comparison
Compare EDRY & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EDRY | SRTS |
|---|---|---|
| Founded | 2018 | 2010 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.6M | 65.5M |
| IPO Year | 2018 | 2016 |
Fundamental Metrics
Financial Performance| Metric | EDRY | SRTS |
|---|---|---|
| Price | $19.55 | $3.87 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 17.0K | ★ 33.4K |
| Earning Date | 06-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,482,000.00 |
| Revenue This Year | $28.30 | $2.00 |
| Revenue Next Year | $10.13 | $34.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.64 | $3.03 |
| 52 Week High | $23.98 | $5.92 |
Technical Indicators
Market Signals| Indicator | EDRY | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 49.60 | 37.09 |
| Support Level | $17.70 | $3.66 |
| Resistance Level | $20.40 | $3.92 |
| Average True Range (ATR) | 1.38 | 0.22 |
| MACD | -0.16 | -0.06 |
| Stochastic Oscillator | 32.94 | 3.03 |
Price Performance
Historical ComparisonAbout EDRY EuroDry Ltd.
EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulk such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers. It operates under one operating and one reportable segment, that of operating dry bulk vessels.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.